Introduction
Clinical pharmacology is the branch of pharmacology concerned with the effects of medicines in humans. It connects fundamental drug research with clinical healthcare by investigating how medicines behave in the human body, how they produce therapeutic and adverse effects, and how their use can be evaluated and improved. It includes research in healthy volunteers and patients, subject to appropriate ethical and regulatory requirements.
Main objectives
Understand drug behavior in humans.
Evaluate therapeutic effects and adverse reactions.
Investigate the relationship between drug exposure and clinical response.
Identify factors that cause variation in drug response.
Support evidence-based medicine selection and use.
Improve the safety and effectiveness of pharmacotherapy.
Major areas
| Area | Description |
|---|---|
Clinical pharmacokinetics | Studies absorption, distribution, metabolism, and excretion of medicines in humans. |
Clinical pharmacodynamics | Studies the relationships between drug concentration, biological response, therapeutic outcomes, and adverse effects. |
Clinical trials | Evaluates investigational medicines through appropriately designed and ethically reviewed human studies. |
Therapeutic drug monitoring | Uses selected drug concentration measurements alongside clinical information to support treatment evaluation for medicines where monitoring is useful. |
Pharmacogenetics | Investigates how genetic variation influences drug response, metabolism, and susceptibility to adverse effects. |
Clinical toxicology | Evaluates harmful effects associated with medicines and other substances in clinical settings. |
Pharmacovigilance | Monitors and evaluates suspected adverse effects and other medicine-related safety problems. |
Pharmacokinetic foundation
Abbreviation
ADME
Components
| Component | Description |
|---|---|
Absorption | Movement of a drug from its administration site into systemic circulation, when applicable. |
Distribution | Movement of a drug between blood and tissues. |
Metabolism | Chemical transformation of a drug by enzymes and other biological processes. |
Excretion | Removal of a drug or its metabolites from the body. |
Pharmacodynamic foundation
Drug-receptor interactions.
Enzyme and transporter interactions.
Concentration-response relationships.
Therapeutic and adverse responses.
Changes in physiological and biochemical functions.
Individual variability
| Factor | Description |
|---|---|
Genetics | Genetic variation can influence drug-metabolizing enzymes, transporters, and drug targets. |
Age | Physiological development and aging can influence drug disposition and response. |
Organ function | Liver and kidney function can influence metabolism and elimination. |
Disease | Illness can change physiological processes and the response to medicines. |
Interactions | Other medicines and relevant substances may alter drug exposure or effects. |
Biological variability | Differences in body composition, physiology, and other biological characteristics can influence treatment outcomes. |
Clinical trial connection
Description
Clinical pharmacology contributes to the design and interpretation of human studies that investigate drug exposure, biological activity, safety, and clinical outcomes.
General stages
| Stage | Description |
|---|---|
Early human investigation | Investigates aspects such as safety, tolerability, pharmacokinetics, and pharmacodynamics under appropriate protocols. |
Patient studies | Evaluates a medicine in people with the relevant condition and investigates potential therapeutic benefit and risks. |
Confirmatory evaluation | Provides additional evidence about clinical benefit, safety, and the medicine's role in treatment. |
Post-authorization evaluation | Continues to assess safety and effectiveness in wider and more diverse populations. |
Ethical requirement
Human research requires appropriate ethical review, informed consent, participant protection, and compliance with applicable regulations.
Clinical pharmacology and personalized medicine
Clinical pharmacology increasingly uses genetic information, biomarkers, drug concentration measurements, and patient characteristics to investigate variation in treatment response. These approaches can support individualized decisions when validated evidence is available.
Common misconceptions
| Misconception | Correction |
|---|---|
Clinical pharmacology is only about prescribing medicines. | It includes human drug research, pharmacokinetic and pharmacodynamic studies, clinical trials, safety monitoring, and evidence evaluation. |
Every patient responds identically to the same medicine. | Drug response varies because of genetic, physiological, pathological, and environmental factors. |
Clinical pharmacology and clinical medicine are identical. | Clinical pharmacology specializes in drug behavior and effects in humans, while clinical medicine covers broader patient assessment and healthcare. |